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ABSTRACT 1 
The inner mitochondrial membrane (IM) is among most protein-rich cellular compartments. The metastable IM 2 
sub-proteome where the concentration of proteins is approaching oversaturation creates a challenging protein 3 
folding environment with high probability for protein malfunction or aggregation. Failure to maintain protein 4 
homeostasis in such a setting can impair functional integrity of the mitochondria and drive clinical 5 
manifestations. The IM is equipped with a series of highly conserved, proteolytic complexes dedicated to the 6 
maintenance of normal protein homeostasis within this mitochondrial sub-compartment. Particularly important 7 
is a group of membrane-anchored metallopeptidases commonly known as m-AAA and i-AAA proteases, and the 8 
ATP-independent Oma1 protease. Herein, we will summarize current biochemical knowledge about these 9 
proteolytic machines and discuss recent advances toward understanding mechanistic aspects of their 10 
functioning.   11 
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INTRODUCTION 1 
Mitochondria are complex organelles involved in a plethora of vital cellular functions including energy 2 
conversion, cofactor and metabolite synthesis, maintenance of ion homeostasis, cell signaling and death 1. Two 3 
membranes of distinctive lipid composition, known as the outer (OM) and inner (IM) membranes segregate 4 
mitochondrial compartments from the rest of the cell and harbor a significant portion of proteins comprising the 5 
mitochondrial proteome. Particularly fascinating is the IM, which is estimated to house over 800 integral and 6 
peripherally associated proteins originating from both nuclear and mitochondrial genomes, and is one of the 7 
major sites of essential mitochondrial functions 2. The extremely protein-rich environment of the IM sub-8 
compartment poses a major homeostatic challenge and necessitates tight control of its biogenesis and 9 
maintenance. Not surprisingly, the failure to properly fold, assemble and maintain protein complexes within the 10 
IM is increasingly recognized as a root cause of a wide spectrum of pathological conditions 3–5. Several 11 
interdependent mechanisms known as mitochondrial quality control (MQC) are involved in the maintenance of 12 
protein homeostasis within the IM. A major facet of MQC that operates in this mitochondrial sub-compartment 13 
is represented by three evolutionarily conserved metallopeptidases: the intermembrane space (IMS)-oriented 14 
AAA (i-AAA) protease, the matrix-oriented AAA (m-AAA) protease, and the Oma1 protease. In this review, 15 
we will summarize current knowledge gained from the biochemical studies focusing on the mechanistic aspects 16 
of these proteolytic machines.   17 
MITOCHONDRIAL AAA METALLOPROTEASES 18 
The AAA+ (ATPases Associated with diverse cellular Activities) metalloproteases in mitochondria are 19 
direct descendants of the bacterial FtsH AAA+ protease 6, and share common domain and structure organization 20 
features with members of the so-called classic clade of AAA proteins 7–9. They are a subgroup of AAA+ 21 
proteases classified as ring-shaped P-loop NTPases 10 - a diverse family of proteins responsible for unfolding 22 
misfolded or damaged polypeptides 11. The proteins of the FtsH family form hexameric complexes that utilize 23 
the energy of coordinated ATP hydrolysis to propel target proteins through the central pore for unfolding 12 24 
(Fig. 1A). A typical AAA+ metalloprotease comprises an N-terminal domain, a AAA+ ATPase domain that 25 
contains the nucleotide binding Walker A and B (also known as NBD1 and NBD2) motifs, as well as the 26 
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Second Region of Homology (SRH) domain 11, and Zn2+ metalloprotease C-terminal domain 7,11. The N-1 
terminal portion is usually the least conserved part of AAA+ metalloproteases 7. Metalloproteinase domains 2 
have either HExxH or variant HxxEH motifs, and belong to the M41 protease domain family 13. In this setup, 3 
histidines bind a Zn2+ ion and keep it in the correct orientation while glutamine takes part in the catalytic 4 
reaction as a proton donor 14 through a “oxyanion hole” mechanism that was described in detail for 5 
Carboxypeptidase A 15. While bacteria are usually equipped with only one FtsH-type metalloprotease 16, the 6 
mitochondria of eukaryotic cells bear several different homologs – the homomeric i-AAA and heteromeric m-7 
AAA, with their active sites facing the IMS and mitochondrial matrix, respectively 11. The following sections 8 
describe these proteolytic machines in a greater detail. 9 
i-AAA PROTEASE 10 
Six copies of the inner membrane-anchored, IMS-facing protein Yme1 (Yta11, also known as YME1L 11 
in mammals) form an active homo-hexameric complex commonly referred to as i-AAA protease 17.  These 12 
eukaryote-specific proteins are believed to have evolved from bacterial FtsH peptidases by losing a 13 
transmembrane helix and substituting an α + β fold with tetratricopeptide repeat (TPR) fold 7,18. It is postulated 14 
that Yme1 proteins have further diverged in the animal kingdom by acquiring an additional domain, Yme1-NN 15 
(at present found only in the Hydra genus), which along with the TPR fold was replaced by Yme1-NC domain 16 
following the evolutionary split between Cnidaria and Bilateria phylae 7. In contrast, Nematoda and Biptera 17 
harbor yet another Yme1 variant, where Yme1-NN is replaced with other domains 7. i-AAA function is highly 18 
conserved in eukaryotes 19.  19 
Most of the current knowledge about i-AAA is derived from studies in yeast. NMR analysis of the yeast 20 
enzyme showed that the N-terminal domain of Yme1 comprises a short mitochondrial targeting sequence, and a 21 
single, 19 kDa polypeptide chain, which in turn contains a core and loosely folded flanking regions. The core 22 
region harbors a fold with five helices, four of which are forming TPR hairpins. Such fold structure is conserved 23 
in most eukaryotes, ranging from yeast to mammals, but has an additional extended loop in some fungi and 24 
plants 7. The N-terminal domain of Yme1 is protein-specific and does not share any homology with the N-25 
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termini of the other AAA+ proteins. These domains mediate hexamerization of Yme1, thereby forming the 1 
central pore structure of the complex that leads a target protein to the complex’s catalytic chamber 7 (Fig. 1A, 2 
B). The remainder of the protein consists of the AAA+ ATPase domain, the conserved SRH motif, the catalytic 3 
(protease) domain, and the C-terminal Calponin Homology (CH) domain 20.  4 
Figure 1. Structural and functional organization of the AAA+ IM metalloproteases. (A) A structural model 5 
of prototypal IM AAA+ protease is presented as a hexameric structure with a distinct metalloprotease domain 6 
(red) and an AAA+ domain (blue) modeled by fitting the crystal structure of the FtsH protease from Thermogota 7 
maritima (3KDS) into the cryoEM envelope from S. cerevisiae m-AAA enzyme (EMD-1712). The IMSD 8 
domain (orange) in the distal part is presented by the solution structure of a portion of human AFG3L2 (2LNA). 9 
Note that the AAA+ and metalloprotease modules are not color-highlighted in top and bottom view projections, 10 
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respectively, for better clarity. The model was generated using the ChimeraX software. (B) i-AAA protease 1 
forms a homo-hexameric complex with the catalytic M41 zinc metalloprotease’s domain (purple) and the AAA+ 2 
ATPase domain (yellow) facing the IMS, which are then followed by the transmembrane spans and the Yme1-3 
specific N-terminus (orange). The enzyme is able to: (1) proteolytically process soluble, IMS-residing 4 
substrates, presumably without engaging its AAA+ module; (2) extract and degrade IM-anchored proteins 5 
through the concerted action of the ATPase and proteolytic domains; or (3) merely unfold/refold them via its 6 
AAA+ module, thus functioning as a chaperone. Various substrates have been identified for both mammalian 7 
and yeast iAAA proteases, which however, in many cases are not orthologous. The insets in panels B and C list 8 
proteins that have been experimentally confirmed as bona fide substrates of each respective protease. The 9 
asterisks or ts (temperature sensitive) acronyms denote proteins that are perceived as substrates upon a condition 10 
when they are damaged, unassembled, and/or misfolded. OM, outer mitochondrial membrane; IM, inner 11 
mitochondrial membrane; IMS, intermembrane space. (C) m-AAA proteases can form either homo- or hetero-12 
oligomeric complexes with their proteolytic (red, pink) and ATPase (blue, dark purple) domains exposed to the 13 
matrix. Similar to the i-AAA enzyme, the m-AAA proteases demonstrate remarkable versatility in their 14 
substrate processing modes. Likewise, the m-AAA substrates appear to differ between mammalian and yeast 15 
systems. More details can be found in the text. 16 
 17 
The E541Q mutation in the HExxH domain of Yme1 disables the enzyme’s catalytic site 21. The SRC 18 
domain also contributes to enzymatic activity by co-localizing conservative arginine residues close to the 19 
catalytic center of the neighboring subunit, thereby boosting catalytic efficiency of the enzyme 22. An intact 20 
AAA+ domain structure with a hydrophobic amino acid at position 354 within the pore loop of Yme1 was 21 
postulated to be critical for substrate unfolding 23, however neither the catalytic domain, nor AAA+ module 22 
appear to play a role in determining substrate specificity. Two helical subdomains of the C-terminal CH domain 23 
appear to be responsible for substrate recognition 21, even though the NH domain also seems to play some role 24 
in substrate binding 21. The ATPase module of Yme1 can translocate proteins through the membrane into the 25 
IMS without engaging the cleavage by the catalytic domain 24 (Fig. 1B). In line with this are the observations 26 
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that i-AAA can perform chaperone-like functions both in vitro 25 and in vivo 26,27. At present, Yme1 appears to 1 
be the only protein with the ATP-dependent chaperone function that operates in the IMS 26. 2 
The recent elegant in vitro studies using an engineered soluble version of mammalian Yme1 ortholog 3 
YME1L – stabilized via replacement of its native transmembrane segment with the cc-hex artificial peptide 4 
permitting the enzyme’s assembly into enzymatically active i-AAA complex in solution – showed that Yme1 5 
recognizes certain specific motifs (degrons) in its substrate proteins, and the simple unfolding of a substrate is 6 
insufficient to initiate degradation 28. While the molecular nature of i-AAA degrons remains to be elucidated, 7 
the study by the Glynn lab identified a F-h-h-F (where h is any hydrophobic residue) as a potential recognition 8 
signal for YME1L 28. Of note, this motif or its variants are found in about 40 proteins comprising the IMS and 9 
IM sub-proteomes 28. Further analyses determined that Yme1 exhibits specificity toward unfolded degrons, but 10 
does not seem to recognize them in a folded state 29. Only when an unfolded degron is recognized, the i-AAA 11 
can subsequently unfurl the rest of the protein and proteolyze it in a processive manner. This is achieved by 12 
active unfolding and feeding of the substrate into the enzyme’s catalytic chamber through the complex’s central 13 
pore using the energy of ATP hydrolysis 28.  14 
In line with the functional versatility of Yme1 are its multifaceted activities within the mitochondria – 15 
the i-AAA has been implicated in a variety of processes including regulation of mitochondrial fission/fusion 16 
mechanism by processing the IM GTPase OPA1 30, and metallopeptidase OMA1 31 – assembly, maintenance, 17 
and quality control of IM proteins and respiratory complexes 32,33; IMS protein transport 24; and the 18 
mitochondrial unfolded protein response (UPRmt) 34. While physiological roles of i-AAA remain to be 19 
clarified, the enzyme’s functional importance is underscored by studies in rodents showing its crucial role in 20 
embryonic development and maintenance of normal mitochondrial populations 35. In addition, a recent clinical 21 
study identified the homozygous R149W mutation in YME1L in patients with an infantile-onset 22 
mitochondriopathy 36. This substitution affects the protein’s maturation and impairs its accumulation within the 23 
mitochondria 36. 24 
m-AAA PROTEASE 25 
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The matrix-facing m-AAA protease has been originally described in yeast as a hetero-hexameric 850 1 
kDa complex consisting of paralogous Yta10 and Yta12 subunits (SPG7/paraplegin and AFG3L2 in humans, 2 
respectively) 37,38 (Fig. 1C), which are well-conserved across the Eukarya 39. In addition to the usual AAA+ and 3 
M41 metallopeptidase domains, these proteins harbor specific IMS domain (IMSD) and two transmembrane 4 
helices at their N-termini 12. In humans, IMSD contains an α + β fold of two alpha helices and five beta sheets 5 
39
.  Both catalytic ATPase domains of m-AAA subunits are exposed to the matrix 25,37 (Fig. 1A). Not only are 6 
these modules responsible for protein unfolding, but they also appear to be specifically driving formation of an 7 
active hexameric m-AAA complex. Swapping of catalytic domains between Yta10 and Yta12 prevents 8 
functionality of the complex, while switching other domains does not 12. Interestingly, hetero-oligomeric 9 
assembly of the Yta10-Yta12 complex is dependent upon the proteolytic domains of both subunits - only two 10 
amino acid substitutions in this region can promote homo-oligomerization of Yta12.  These mutations have 11 
been allocated to the interface between promoters in the m-AAA hexamer 12. Coordinated ATP hydrolysis is 12 
ensured by a complex signaling network within the AAA ring with the primary role given to the arginine finger, 13 
followed by the inter-subunit signaling motif (located at the end of helix α7) and the pore loop-2 region of 14 
Yta10 40. Similar to the AAA+ domain of Yme1, the ATPase domains of Yta10 and Yta12 were shown to exert 15 
some chaperone-like properties 25,37. The molecular organization and architecture of m-AAA appears to be 16 
similar between eukaryotes 39,41. Human m-AAA complexes can rescue yeast cells with m-AAA deletions, 17 
which points to a highly conserved structure and function 41,42.  18 
Structural analysis of human SPG7 revealed that this domain comprises a large beta-sheet consisting of 19 
five parallel strands, surrounded by two alpha helices, and terminated with four antiparallel alpha helices at the 20 
C-terminus. The domain’s ATP/ADP-binding site is situated between these structures 43. The Walker A and B 21 
motifs in SPG7 are highly conserved and are responsible for handling ADP and Mg2+ ions, respectively 43. 22 
Activity of the catalytic domains of each subunit is boosted in hexameric m-AAA complex due to inter-subunit 23 
influence of the Walker A motifs from neighboring subunits, and resulting cooperative mechanism allowing 24 
simultaneous coordinated ATP hydrolysis by all subunits of the complex 40. In addition to heteromeric 25 
SPG7/AFG3L2 m-AAA complexes, human mitochondria contain m-AAA variants formed by six copies of 26 
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AFG3L2 41,42 that have overlapping functionality 44. Interestingly, SPG7 does not appear to homo-oligomerize, 1 
likely due to the fact that its own maturation requires AFG3L2 45. Additionally, murine mitochondria contain 2 
yet another AFG3L2 paralog, Afg3L1, which has transformed into a pseudogene in humans 45,46. The abundance 3 
of each variant complex appears to be determined merely by abundance of a particular subunit 42. Inceptive 4 
evidence of differential substrate preference/specificity was provided for both murine and human homo- versus 5 
hetero-oligomeric m-AAA complexes 20. Of note, tissue–specific patterns of the m-AAA subunit composition 6 
have been observed in rodents 42, however the functional significance of this observation remains to be clarified.  7 
Numerous studies have catalogued information about mutations in the m-AAA complex. For example, 8 
mutations in SPG7’s catalytic center or hydrophobic core, such as A510V, completely abrogate m-AAA 9 
complex activity 43. Interestingly, however, a constitutively active R688Q substitution, which renders SPG7 10 
insusceptible to AFG3L2-mediated maturation, has also been reported 47. Several mutations affecting the 11 
function of AFG3L2’s peptidase domain have also been described. Most of these substitutions occur in the 12 
region spanning the amino acid residues 654 through 700 48–50. Additionally, the E575Q, M625I, and K354A 13 
mutations disable the catalytic center of the enzyme 51–53, while the Y616C substitution prevents hetero-14 
oligomerization of AFG3L2 with SPG7 54; and the E408Q mutation ablates ATPase activity by disrupting the 15 
Walker B motif 52. Given the detrimental effect of the abovementioned AFG3L2 and paraplegin mutations, their 16 
association with clinical manifestations is not surprising. Many of these substitutions manifest in neurological 17 
pathologies such as hereditary spastic paraplegia (HSP type 7), spinocerebellar ataxia type 28 (SCA28), and 18 
spastic ataxia-neuropathy syndrome (SPAX5). More detailed reviews on the roles of m-AAA protease in 19 
neuronal dysfunctions can be found elsewhere 4.  20 
The molecular architecture of m-AAA appears to be similar to that of the i-AAA protease 7,39. It is 21 
therefore plausible that the mechanism of substrate recognition by m-AAA may be similar to that reported for 22 
YME1L. Available reports suggest that AAA proteases may be finding their substrates in the protein-rich IM by 23 
recognizing specific patterns that become accessible upon polypeptide’s domain unfolding and/or its projection 24 
from the membrane face. Consistent with this idea, studies in yeast have determined that a certain length of the 25 
polypeptide’s unfolded region is required for substrate retention and processing by m-AAA 55. However, 26 
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molecular determinants of substrate recognition by m-AAA, as well as identity of potential degrons, remain to 1 
be investigated.  2 
Just like i-AAA, the m-AAA protease can perform both proteolytic and chaperoning functions. The 3 
enzyme is responsible for maturation, maintenance, and quality control of membrane proteins on the matrix side 4 
of the IM 56,57 as well as certain proteins in the matrix 58 (Fig. 1C) – most notably the key ribosomal protein 5 
MRPL32 56. The m-AAA protease is also known to regulate mitochondrial fusion via influencing cleavage of 6 
the OPA1 GTPase, albeit likely in an indirect manner 52. Interestingly, both m-AAA and i-AAA complexes can 7 
degrade IM-anchored polypeptides with at least a short tail exposed to the matrix or IMS respectively by ATP 8 
dependent unfolding and translocation of the proteins across the membrane for degradation 59. An interesting 9 
example of protein translocation that is uncoupled from degradation has been reported in yeast, wherein m-10 
AAA dislocates fungi-specific protein cytochrome c peroxidase (Ccp1) from its initial position in the IM and 11 
correctly positions it for subsequent cleavage by rhomboid protease Pcp1 60,61. The intact central pore loop and 12 
the insertion of Ccp1 into the protease’s central channel are critical requirements of this process 61.  13 
OMA1 PROTEASE 14 
Initially postulated to be a backup protease for m-AAA proteolytic module, Oma1 belongs to the M48C 15 
family of conserved metalloproteases 62 with homologs found in both prokaryotes and eukaryotes 63. Some 16 
notable exceptions include Nematoda and Trematoda worms and certain flies (Drosophilidae), which appear to 17 
have lost OMA1 homologs throughout their evolution. The enzyme comprises an eukaryote-specific N-terminal 18 
region 63 and a M48 metallopeptidase domain 13. Unlike i-AAA and m-AAA proteases, Oma1 lacks the ATPase 19 
domain, and thus is ATP-independent (Fig. 2A, B). Amino acid sequence analysis predicts Oma1 to contain two 20 
hydrophobic transmembrane segments (residues 63-83 and 220-240 in S. cerevisiae) 62 which anchor OMA1 to 21 
the IM and orient the enzyme’s active site to the IMS 64 (Fig. 2A). However, the experimental evidence rather 22 
suggests that the enzyme contains a single transmembrane segment 65. Mutations of catalytic glutamate and 23 
histidine residues within the protease’s HExxH catalytic domain ablate its enzymatic activity 63,66. 24 
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Oma1 is assumed to exist as a homo-oligomeric complex 66,67. The protease appears to be largely 1 
dormant under basal conditions, but becomes rapidly activated by various homeostatic challenges such as loss 2 
of mitochondrial membrane potential, oxidative, and heat stress 65,66,68 (Fig. 2C). With no available structural 3 
data on Oma1, the mechanism of its stress activation remains largely obscure. However, several insights have 4 
emerged from studies on the yeast and mammalian enzyme. Probing yeast mitochondria-derived Oma1 5 
oligomers by limited proteolysis revealed that conditions of mitochondrial stress alter conformation and/or 6 
stability of the protease complex, while constituent Oma1 subunits remain stable 66. In contrast, mammalian 7 
OMA1 was reported to undergo autocleavage upon its activation 64,65,68. OMA1 is presumed to self-cleave at the 8 
C-terminal residues 443–452 upon mitochondrial depolarization 68. Of note, the C-terminal moiety of metazoan 9 
Oma1 is significantly extended as compared to the yeast enzyme. However, a more recent study by Rainbolt et 10 
al. has challenged the OMA1 self-cleavage model by demonstrating that degradation of activated OMA1 occurs 11 
via YME1L-mediated proteolysis 69. Mammalian OMA1 harbors another metazoan-specific element – a 12 
positively charged N-terminal region spanning amino acid residues 144-163. This region appears to be 13 
important for OMA1 activation – mutations in the residues constituting the segment impair the enzyme’s stress-14 
activation and processing 65.  15 
Figure 2.  Structural and functional 16 
organization of OMA1 protease. (A) 17 
Predicted molecular organization of 18 
mammalian OMA1. The enzyme comprises 19 
the IMS-facing proteolytic domain (grey; the 20 
position of the HExxH catalytic motif is 21 
highlighted in purple), the transmembrane 22 
segment (teal), and a shorter N-terminal α 23 
helix that likely helps to further stabilize the 24 
enzyme’s association with the IM (navy). The 25 
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 12
N-terminal moiety of vertebrate Oma1 orthologs also contains a stretch of charged amino acid residues that has 1 
been proposed to participate in stress-induced activation of the enzyme. (B) Predicted structural model of the 2 
yeast Oma1 protease. The model was produced using the iTASSER prediction software and further processed 3 
using the ChimeraX. (C) OMA1 exists as a largely dormant, homo-oligomeric complex that is activated upon 4 
indicated homeostatic insults. While the exact mechanism behind this process remains to be clarified, changes in 5 
conformation of the Oma1 oligomer were proposed to trigger the enzyme’s activation. The inset shows currently 6 
known substrates of Oma1. The yeast Cox1 protein (marked with the asterisk) is degraded by Oma1 in a subset 7 
of cytochrome oxidase assembly mutants. Similarly, Oma1 appears to specifically degrade temperature sensitive 8 
(ts), misfolding-prone variants of the IM translocase Oxa1 and phosphatidylserine decarboxylase Psd1. More 9 
details are available in the text. The current Oma1 substrate repertoire includes the misfolded and/or 10 
unassembled translocase Oxa1 63, respiratory complex IV subunit Cox1 67, and phosphatidylserine 11 
decarboxylase Psd1 in yeast  70; and the GTPase OPA1 52,64,65 and complex III assembly factor UQCC3 71 in 12 
mammals (Fig. 2C). The mechanisms by which Oma1 selects and recognizes its substrates remain to be 13 
determined. 14 
 15 
Heterozygous mutations in conserved His-69, Glu-272, and Asp-365 residues of OMA1 have been 16 
reported in several patients afflicted with familial and sporadic forms of amyotrophic lateral sclerosis 72. While 17 
molecular effects of these mutations remain to be tested, these substitutions are likely to exert negative effects 18 
due to the likely homo-oligomeric nature of the OMA1 complex.  19 
FUNCTIONAL INTERACTIONS OF THE IM METALLOPEPTIDASES 20 
Functional interactions between the IM proteases can manifest in various forms including: (1) specific 21 
condition-defined reciprocal proteolysis of the enzymes; (2) sequential processing or degradation of shared 22 
substrates; and/or (3) formation of supramolecular complexes to facilitate processing of certain substrates or 23 
modulate enzymes’ activity. These functional scenarios are not mutually exclusive, as –for instance – 24 
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exemplified by versatile functional interactions between Oma1 and i-AAA proteases. The following text will 1 
discuss some of these activities. 2 
The study by Rainbolt et al. reported that mammalian YME1L and OMA1 can reciprocally regulate 3 
each other’s steady state levels in response to membrane depolarization and ATP levels, respectively 69 (Fig. 4 
3A). This work suggested that the i-AAA is responsible for degradation of depolarization-activated OMA1, 5 
whereas ATP-independent OMA1 peptidase may be involved in proteolytic processing of YME1L when 6 
mitochondrial ATP pools are critically low. At present, it is unclear whether this modus operandi is specific to 7 
mammalian enzymes – the stress-activated Oma1 appears to remain stable in yeast 65,66. On the other hand, 8 
combined deletion of fungal Oma1 and Yme1 leads to a severe synthetic genetic effect 66. Such synergy, 9 
however, may relate to functional cooperation between the enzymes towards certain substrates. For example, a 10 
recent study by Ogunbona et al. demonstrated in yeast that Oma1 and Yme1 are responsible for the processing 11 
of temperature-sensitive mutant phosphatidylserine decarboxylase Psd1 70. Psd1 is a mitochondrial protein 12 
comprised of non-covalently associated α- (required for enzymatic activity) and β-subunits, which are separated 13 
as a result of autocatalysis. The i-AAA alone can degrade post-autocatalysis aggregated β-subunits. However, 14 
when the latter process is compromised, Oma1 is required to cleave the misfolded temperature-sensitive Psd1 15 
precursor, which is subsequently degraded by Yme1 70. Of note, similar cooperation has been reported for the 16 
Oma1 and m-AAA proteases during proteolytic removal of the temperature-sensitive L240S mutant of the IM 17 
insertase Oxa1 63. 18 
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Figure 3.  Functional cooperation between the i-AAA and OMA1 proteases. (A) OMA1 is activated by 32 
conditions of mitochondrial stress. Original reports suggested that the activated protease undergoes 33 
autoproteolysis (1), thereby eliminating over-reactive enzyme when the stressed condition is over. However, a 34 
recent report proposed an alternative model, wherein the i-AAA is responsible for degradation of stress-35 
activated OMA1 (2). Reciprocally, OMA1 may be involved in proteolytic cleavage of YME1L when 36 
mitochondrial ATP levels are attenuated (3). (B) Metalloproteases YME1L and OMA1 cooperate in proteolytic 37 
processing of long forms of GTPase OPA1 (L-OPA1). This variant is important for mitochondrial fusion and 38 
normal cristae ultrastructure. L-OPA1 forms harbor two physically separate cleavage sites, S1 and S2, which are 39 
recognized by OMA1 and YME1L, respectively. Cleavage of L-OPA by either protease yields short forms of 40 
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the enzyme, S-OPA1, which facilitates partitioning of the mitochondrial network. The i-AAA protease appears 1 
to be the key enzyme mediating L-OPA1 processing under non-stress conditions, yielding nearly equimolar 2 
amounts of L-OPA1 and S-OPA1 and thus balances fusion and fission of the mitochondrial network. OMA1 3 
exhibits little or no involvement in L-OPA1 processing under non-stress conditions. Homeostatic challenges or 4 
mitochondrial dysfunction trigger stress-activation of OMA1, which mediates rapid processing of the entire L-5 
OPA1 pool into S-OPA1 forms, thereby stimulating mitochondrial fission and massive fragmentation of the 6 
mitochondrial network. Further details can be found in the text. Representative confocal fluorescent images 7 
show MitoTracker Red-stained mitochondrial network in cultured SH-SY5Y neurobalstoma cells that have been 8 
challenged or not with an uncoupler CCCP.   9 
 10 
Another well-characterized shared substrate of the IM metallopeptidases is mammalian dynamin-related 11 
GTPase OPA1 65,73. This protein – which has emerged as a key mediator of the IM fusion – is present in 12 
multiple variants in various tissues due to alternative splicing and processing resulting in six different isoforms 13 
in mice 74 and eight in humans 75.  Long OPA1 isoforms (L-OPA1) are produced due to alternative splicing; 14 
these polypeptides contain two physically separate cleavage sites, designated S1 and S2, which are recognized 15 
by OMA1 and YME1L, respectively (Fig. 3B). Cleavage of L-OPA by either protease yields short forms of 16 
OPA1, known as S-OPA1 (reviewed in 76,77). However, in this case OMA1 and YME1L seem to engage under 17 
different physiological conditions. The i-AAA protease appears to be the key enzyme mediating L-OPA1 18 
processing under non-stress conditions; its activity yields roughly equimolar amounts of long and short OPA1 19 
isoforms - the state required for an optimal fusion/fission balance of the mitochondrial network. Additionally, 20 
YME1L’s activity toward L-OPA1 has been proposed to further stimulate IM fusion during conditions that 21 
demand increased bioenergetics capacity 78. In contrast, OMA1 exhibits little or no involvement in L-OPA1 22 
processing under basal conditions. However, it becomes activated in response to various homeostatic insults 23 
(Fig. 2C) and mediates rapid conversion of all L-OPA1 isoforms into the short variant, thereby triggering IM 24 
fission and subsequent partitioning of the mitochondrial network 30,64,65,73 (Fig. 3C). The balance between 25 
proteolytic activities of i-AAA and OMA1 appears to be crucial for normal cell functioning. For example, 26 
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cardiac-specific inactivation of YME1L in mice triggers OMA1 activation and subsequent mitochondrial 1 
fragmentation, and metabolic alterations in cardiac tissue. These events further lead to the development of 2 
dilated cardiomyopathy and ultimately heart failure. Remarkably, these pathological conditions can be 3 
effectively alleviated by the additional deletion of OMA1, leading to L-OPA1 stabilization and consequent 4 
restoration of the mitochondrial network 35.  5 
Of note, the yeast OPA1 ortholog Mgm1 is not a substrate of either i-AAA or Oma1. The fungal 6 
GTPase is processed by the rhomboid serine protease Pcp1 (PARL in mammals), which also yields equimolar 7 
amounts of L-Mgm1 and its single short isoform (reviewed in 79). 8 
Both i-AAA and m-AAA proteases can form super-molecular structures with other proteins that are not directly 9 
required for their proteolytic activity.  In some cases, such assemblies have been reported to display regulatory 10 
features, associate with specific substrate recruitment activities, or facilitate protease-substrate interactions. In 11 
yeast, nematodes, and mammals, the prohibitins Phb1 and Phb2 form a large IM-anchored ring-shaped complex 12 
of 1.2 MDa (PHB) (reviewed in 80). The PHB complex assembles together with independently formed m-AAA 13 
protease 80,81, however the functional significance of this interaction remains unclear.  Osman et al. 80 speculated 14 
that such assembly may be assisting recruitment of the m-AAA complex to specific membrane sites where lipid 15 
composition could activate the protease and/or modulate its activity. An additional component of the PHB-m-16 
AAA complex has been reported recently 81.  The previously uncharacterized protein c2orf47 (now named 17 
MAIP1, for m-AAA-protease interacting protein 1) is the matrix protein peripherally attached to the IM. 18 
MAIP1 is a binding partner, but not a substrate of the m-AAA. It facilitates maturation of the EMRE subunit of 19 
mitochondrial Ca2+ uniporter (MCU) by protecting it from degradation by YME1L. Interestingly, non-20 
assembled EMRE also appears to be the substrate of m-AAA, however its cleavage seems to be independent of 21 
its association with MAIP1 81.  22 
The i-AAA protease is also known to be a part of supramolecular asemblies regulating its proteolytic 23 
activity.  The study by Dunn et al. 82 revealed that the yeast i-AAA can associate into a structure comprising 24 
proteins Mgr1 and Mgr3. While this assembly is not essential for proteolysis per se, it appears to improve the 25 
protease’s binding to model substrates, thereby suggesting an adaptor role for the Mgr1-Mgr3 subcomplex 82. 26 
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Another report studying i-AAA-mediated turnover of disease allele-mimicking mutant forms of phospholipid 1 
transacylase Taz1 demonstrated that degradation of these proteins is impaired but not ablated in the absence of 2 
Mgr1 and Mgr3, further indicating their role in facilitating Yme1 function 83. 3 
Interestingly, in the abscense of the adaptor subcomplex, Yme1 may function as a chaperone 84.  4 
Similarly, the human YME1L protease also exists in several macromolecular complexes ranging from 600 to 5 
2000 kDa in size 32,85.  At present, however, no functional homologs of the Mgr1-Mgr3 subcomplex have been 6 
identified outside of  fungi. Instead, the recent study described a novel supramlecular complex consisting of the 7 
YME1L, membrane scaffold stomatin-like protein SLP2, and the rhomboid protease PARL 85. This ~2 MDa 8 
complex, named SPY,  appears to facilitate proteolytic activity of i-AAA under conditions of  high substrate 9 
load; in this role it resembles the PHB-mAAA supercomplex and may exert a modulatory effect on i-AAA 10 
actvity towards specific substrates 85. 11 
CONCLUDING REMARKS 12 
A significant body of experimental data pertaining to the IM metalloproteases has been accumulated 13 
since identification and initial characterization of the i-AAA enzyme more than two decades ago 15,83. 14 
Nevertheless, despite intensive studies by numerous labs around the world, many outstanding questions remain 15 
to be addressed. For example how the IM proteases, which appear to be predominantly localized to the inner 16 
boundary membrane region of the IM 88,89 survey and access substrate proteins residing in the cristae 17 
compartments? Further challenges for the future include identification of substrate repertoires for each IM 18 
metallopeptidase, understanding structural bases for selective substrate recognition, and either modulation or 19 
activation of enzymes’ proteolytic function. The physiological roles of the IM proteases under basal and 20 
homeostasis-perturbing conditions represent another exciting issue. While multiple lines of evidence indicate 21 
functional overlap and apparent case or condition-specific cooperation of the IM metalloproteases in processing 22 
various substrates, the prospective therapeutic significance of enzymes like Oma1 has begun to emerge. These 23 
versatile enzymes are no longer viewed as mere “custodians” of the IM involved in simple removal of damaged 24 
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or surplus proteins. The fine-tuned, multifaceted roles of the IM metalloproteases in mitochondrial and cellular 1 
physiology are being increasingly recognized and await further investigations.  2 
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hydrolyzing enzyme; IMSD, IMS domain; HSP, hereditary spastic paraplegia; SCA, spinocerebellar ataxia; 2 
SPAX, spastic ataxia-neuropathy syndrome; MCU, mitochondrial calcium uniporter; PHB, prohibitin complex. 3 
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Figure 1. Structural and functional organization of the AAA+ IM metalloproteases. (A) A structural model of 
prototypal IM AAA+ protease is presented as a hexameric structure with a distinct metalloprotease domain 
(red) and an AAA+ domain (blue) modeled by fitting the crystal structure of the FtsH protease from 
Thermogota maritima (3KDS) into the cryoEM envelope from S. cerevisiae m-AAA enzyme (EMD-1712). The 
IMSD domain (orange) in the distal part is presented by the solution structure of a portion of human AFG3L2 
(2LNA). Note that the AAA+ and metalloprotease modules are not color-highlighted in top and bottom view 
projections, respectively, for better clarity. The model was generated using the ChimeraX software.  
(B) i-AAA protease forms a homo-hexameric complex with the catalytic M41 zinc metalloprotease’s domain 
(purple) and the AAA+ ATPase domain (yellow) facing the IMS, which are then followed by the 
transmembrane spans and the Yme1-specific N-terminus (orange). The enzyme is able to: (1) proteolytically 
process soluble, IMS-residing substrates, presumably without engaging its AAA+ module; (2) extract and 
degrade IM-anchored proteins through the concerted action of the ATPase and proteolytic domains; or (3) 
merely unfold/refold them via its AAA+ module, thus functioning as a chaperone. Various substrates have 
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been identified for both mammalian and yeast iAAA proteases, which however, in many cases are not 
orthologous. The insets in panels B and C list proteins that have been experimentally confirmed as bona fide 
substrates of each respective protease. The asterisks or ts (temperature sensitive) acronyms denote 
proteins that are perceived as substrates upon a condition when they are damaged, unassembled, and/or 
misfolded. OM, outer mitochondrial membrane; IM, inner mitochondrial membrane; IMS, intermembrane 
space.  
(C) m-AAA proteases can form either homo- or hetero-oligomeric complexes with their proteolytic (red, 
pink) and ATPase (blue, dark purple) domains exposed to the matrix. Similar to the i-AAA enzyme, the m-
AAA proteases demonstrate remarkable versatility in their substrate processing modes. Likewise, the m-AAA 
substrates appear to differ between mammalian and yeast systems. More details can be found in the text.  
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Figure 2.  Structural and functional organization of OMA1 protease. (A) Predicted molecular organization of 
mammalian OMA1. The enzyme comprises the IMS-facing proteolytic domain (grey; the position of the 
HExxH catalytic motif is highlighted in purple), the transmembrane segment (teal), and a shorter N-terminal 
α helix that likely helps to further stabilize the enzyme’s association with the IM (navy). The N-terminal 
moiety of vertebrate Oma1 orthologs also contains a stretch of charged amino acid residues that has been 
proposed to participate in stress-induced activation of the enzyme.  
(B) Predicted structural model of the yeast Oma1 protease. The model was produced using the iTASSER 
prediction software and further processed using the ChimeraX.  
(C) OMA1 exists as a largely dormant, homo-oligomeric complex that is activated upon indicated 
homeostatic insults. While the exact mechanism behind this process remains to be clarified, changes in 
conformation of the Oma1 oligomer were proposed to trigger the enzyme’s activation. The inset shows 
currently known substrates of Oma1. The yeast Cox1 protein (marked with the asterisk) is degraded by 
Oma1 in a subset of cytochrome oxidase assembly mutants. Similarly, Oma1 appears to specifically degrade 
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temperature sensitive (ts), misfolding-prone variants of the IM translocase Oxa1 and phosphatidylserine 
decarboxylase Psd1. More details are available in the text.  
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Figure 3.  Functional cooperation between the i-AAA and OMA1 proteases. (A) OMA1 is activated by 
conditions of mitochondrial stress. Original reports suggested that the activated protease undergoes 
autoproteolysis (1), thereby eliminating over-reactive enzyme when the stressed condition is over. However, 
a recent report proposed an alternative model, wherein the i-AAA is responsible for degradation of stress-
activated OMA1 (2). Reciprocally, OMA1 may be involved in proteolytic cleavage of YME1L when 
mitochondrial ATP levels are attenuated (3).  
(B) Metalloproteases YME1L and OMA1 cooperate in proteolytic processing of long forms of GTPase OPA1 (L-
OPA1). This variant is important for mitochondrial fusion and normal cristae ultrastructure. L-OPA1 forms 
harbor two physically separate cleavage sites, S1 and S2, which are recognized by OMA1 and YME1L, 
respectively. Cleavage of L-OPA by either protease yields short forms of the enzyme, S-OPA1, which 
facilitates partitioning of the mitochondrial network. The i-AAA protease appears to be the key enzyme 
mediating L-OPA1 processing under non-stress conditions, yielding nearly equimolar amounts of L-OPA1 and 
S-OPA1 and thus balances fusion and fission of the mitochondrial network. OMA1 exhibits little or no 
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involvement in L-OPA1 processing under non-stress conditions. Homeostatic challenges or mitochondrial 
dysfunction trigger stress-activation of OMA1, which mediates rapid processing of the entire L-OPA1 pool 
into S-OPA1 forms, thereby stimulating mitochondrial fission and massive fragmentation of the 
mitochondrial network. Further details can be found in the text. Representative confocal fluorescent images 
show MitoTracker Red-stained mitochondrial network in cultured SH-SY5Y neurobalstoma cells that have 
been challenged or not with an uncoupler CCCP.  
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